Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 6, 2025Open Access

Economic evaluation of non-pharmacological interventions for fatigue in patients with long-term medical conditions

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMon Mon-YeeCBChristopher BurtonJLJoanna Leaviss

Discussion

Loading...

Member takes

Overview

Decision analysis reveals cost-effective fatigue interventions in chronic patients, suggesting further research is warranted.

Key Points

  • Fatigue significantly impacts patients with chronic medical conditions, highlighting the need for effective interventions.
  • Non-pharmacological interventions like physical activity and mindfulness showed positive incremental net monetary benefit when compared to usual care.
  • Decision-analytic modeling evaluated intervention costs and quality-adjusted life years gained from a UK NHS perspective.
  • Future research should explore the cost-effectiveness of these interventions across diverse chronic conditions.

Cite This Study

Mon-Yee et al. (2025) studied this question.

synapsesocial.com/papers/689a0f99e6551bb0af8d167chttps://doi.org/10.1101/2025.08.01.25332798
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effectiveness of non-pharmacological Interventions For Fatigue in Long term conditions (EIFFEL) - systematic review and network meta-analysis2025 · 2 citations
  2. 2Physical Activity to Reduce Fatigue in Rheumatoid Arthritis: A Randomized Controlled Trial2017 · 119 citations
  3. 3Measurement properties of instruments to measure the fatigue domain of vitality capacity in community-dwelling older people: an umbrella review of systematic reviews and meta-analysis2023 · 21 citations
  4. 4Cost-effectiveness of cognitive behavioural and personalized exercise interventions for reducing fatigue in inflammatory rheumatic diseases2023 · 10 citations
  5. 5Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis2021 · 14 citations